カテゴリー： Market Monitor Global, 世界, 医療/バイオ

ナロキセゴールの世界市場見通し2023年-2029年

◆英語タイトル：Naloxegol Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5794）

◆商品コード：MMG23JU5794
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月
◆ページ数：62
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥487,500	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥633,750	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥731,250	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Naloxegol Market 調査レポートは次の情報を含め、グローバルにおけるのナロキセゴール市場規模と予測を収録しています。・世界のナロキセゴール市場：売上、2018年-2023年、2024年-2029年
・世界のナロキセゴール市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のナロキセゴール市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「錠剤」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

ナロキセゴールのグローバル主要企業は、MOVANTIK、 AstraZeneca、 Aurobindo、 MSN Life Sciences、 Lepu、 Daiichi Sankyo Company、 Knight Therapeutics、 Kyowa Kirin International、 Nektar Therapeutics、 RedHill Biopharma Ltd.などです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、ナロキセゴールのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界のナロキセゴール市場：タイプ別、2018年-2023年、2024年-2029年
世界のナロキセゴール市場：タイプ別市場シェア、2022年
・錠剤、カプセル

世界のナロキセゴール市場：用途別、2018年-2023年、2024年-2029年
世界のナロキセゴール市場：用途別市場シェア、2022年
・薬局、病院、診療所、その他

世界のナロキセゴール市場：地域・国別、2018年-2023年、2024年-2029年
世界のナロキセゴール市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業におけるナロキセゴールのグローバル売上、2018年-2023年
・主要企業におけるナロキセゴールのグローバル売上シェア、2022年
・主要企業におけるナロキセゴールのグローバル販売量、2018年-2023年
・主要企業におけるナロキセゴールのグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
MOVANTIK、 AstraZeneca、 Aurobindo、 MSN Life Sciences、 Lepu、 Daiichi Sankyo Company、 Knight Therapeutics、 Kyowa Kirin International、 Nektar Therapeutics、 RedHill Biopharma Ltd.

*************************************************************

・調査・分析レポートの概要
ナロキセゴール市場の定義
市場セグメント
世界のナロキセゴール市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のナロキセゴール市場規模
世界のナロキセゴール市場規模：2022年 VS 2029年
世界のナロキセゴール市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのナロキセゴールの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のナロキセゴール製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：錠剤、カプセル
ナロキセゴールのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：薬局、病院、診療所、その他
ナロキセゴールの用途別グローバル売上・予測

・地域別市場分析
地域別ナロキセゴール市場規模 2022年と2029年
地域別ナロキセゴール売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
MOVANTIK、 AstraZeneca、 Aurobindo、 MSN Life Sciences、 Lepu、 Daiichi Sankyo Company、 Knight Therapeutics、 Kyowa Kirin International、 Nektar Therapeutics、 RedHill Biopharma Ltd.
...

This report aims to provide a comprehensive presentation of the global market for Naloxegol, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Naloxegol. This report contains market size and forecasts of Naloxegol in global, including the following market information:
Global Naloxegol Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Naloxegol market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Tablet Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Naloxegol include MOVANTIK, AstraZeneca, Aurobindo, MSN Life Sciences, Lepu, Daiichi Sankyo Company, Knight Therapeutics, Kyowa Kirin International and Nektar Therapeutics, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Naloxegol companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Naloxegol Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Naloxegol Market Segment Percentages, by Type, 2022 (%)
Tablet
Capsule
Global Naloxegol Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Naloxegol Market Segment Percentages, by Application, 2022 (%)
Pharmacy
Hospital
Clinic
Others
Global Naloxegol Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Naloxegol Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Naloxegol revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Naloxegol revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
MOVANTIK
AstraZeneca
Aurobindo
MSN Life Sciences
Lepu
Daiichi Sankyo Company
Knight Therapeutics
Kyowa Kirin International
Nektar Therapeutics
RedHill Biopharma Ltd.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Naloxegol, market overview.
Chapter 2: Global Naloxegol market size in revenue.
Chapter 3: Detailed analysis of Naloxegol company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Naloxegol in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Naloxegol Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Naloxegol Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Naloxegol Overall Market Size
2.1 Global Naloxegol Market Size: 2022 VS 2029
2.2 Global Naloxegol Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Naloxegol Players in Global Market
3.2 Top Global Naloxegol Companies Ranked by Revenue
3.3 Global Naloxegol Revenue by Companies
3.4 Top 3 and Top 5 Naloxegol Companies in Global Market, by Revenue in 2022
3.5 Global Companies Naloxegol Product Type
3.6 Tier 1, Tier 2 and Tier 3 Naloxegol Players in Global Market
3.6.1 List of Global Tier 1 Naloxegol Companies
3.6.2 List of Global Tier 2 and Tier 3 Naloxegol Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Naloxegol Market Size Markets, 2022 & 2029
4.1.2 Tablet
4.1.3 Capsule
4.2 By Type – Global Naloxegol Revenue & Forecasts
4.2.1 By Type – Global Naloxegol Revenue, 2018-2023
4.2.2 By Type – Global Naloxegol Revenue, 2024-2029
4.2.3 By Type – Global Naloxegol Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Naloxegol Market Size, 2022 & 2029
5.1.2 Pharmacy
5.1.3 Hospital
5.1.4 Clinic
5.1.5 Others
5.2 By Application – Global Naloxegol Revenue & Forecasts
5.2.1 By Application – Global Naloxegol Revenue, 2018-2023
5.2.2 By Application – Global Naloxegol Revenue, 2024-2029
5.2.3 By Application – Global Naloxegol Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Naloxegol Market Size, 2022 & 2029
6.2 By Region – Global Naloxegol Revenue & Forecasts
6.2.1 By Region – Global Naloxegol Revenue, 2018-2023
6.2.2 By Region – Global Naloxegol Revenue, 2024-2029
6.2.3 By Region – Global Naloxegol Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Naloxegol Revenue, 2018-2029
6.3.2 US Naloxegol Market Size, 2018-2029
6.3.3 Canada Naloxegol Market Size, 2018-2029
6.3.4 Mexico Naloxegol Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Naloxegol Revenue, 2018-2029
6.4.2 Germany Naloxegol Market Size, 2018-2029
6.4.3 France Naloxegol Market Size, 2018-2029
6.4.4 U.K. Naloxegol Market Size, 2018-2029
6.4.5 Italy Naloxegol Market Size, 2018-2029
6.4.6 Russia Naloxegol Market Size, 2018-2029
6.4.7 Nordic Countries Naloxegol Market Size, 2018-2029
6.4.8 Benelux Naloxegol Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Naloxegol Revenue, 2018-2029
6.5.2 China Naloxegol Market Size, 2018-2029
6.5.3 Japan Naloxegol Market Size, 2018-2029
6.5.4 South Korea Naloxegol Market Size, 2018-2029
6.5.5 Southeast Asia Naloxegol Market Size, 2018-2029
6.5.6 India Naloxegol Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Naloxegol Revenue, 2018-2029
6.6.2 Brazil Naloxegol Market Size, 2018-2029
6.6.3 Argentina Naloxegol Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Naloxegol Revenue, 2018-2029
6.7.2 Turkey Naloxegol Market Size, 2018-2029
6.7.3 Israel Naloxegol Market Size, 2018-2029
6.7.4 Saudi Arabia Naloxegol Market Size, 2018-2029
6.7.5 UAE Naloxegol Market Size, 2018-2029
7 Naloxegol Companies Profiles
7.1 MOVANTIK
7.1.1 MOVANTIK Company Summary
7.1.2 MOVANTIK Business Overview
7.1.3 MOVANTIK Naloxegol Major Product Offerings
7.1.4 MOVANTIK Naloxegol Revenue in Global Market (2018-2023)
7.1.5 MOVANTIK Key News & Latest Developments
7.2 AstraZeneca
7.2.1 AstraZeneca Company Summary
7.2.2 AstraZeneca Business Overview
7.2.3 AstraZeneca Naloxegol Major Product Offerings
7.2.4 AstraZeneca Naloxegol Revenue in Global Market (2018-2023)
7.2.5 AstraZeneca Key News & Latest Developments
7.3 Aurobindo
7.3.1 Aurobindo Company Summary
7.3.2 Aurobindo Business Overview
7.3.3 Aurobindo Naloxegol Major Product Offerings
7.3.4 Aurobindo Naloxegol Revenue in Global Market (2018-2023)
7.3.5 Aurobindo Key News & Latest Developments
7.4 MSN Life Sciences
7.4.1 MSN Life Sciences Company Summary
7.4.2 MSN Life Sciences Business Overview
7.4.3 MSN Life Sciences Naloxegol Major Product Offerings
7.4.4 MSN Life Sciences Naloxegol Revenue in Global Market (2018-2023)
7.4.5 MSN Life Sciences Key News & Latest Developments
7.5 Lepu
7.5.1 Lepu Company Summary
7.5.2 Lepu Business Overview
7.5.3 Lepu Naloxegol Major Product Offerings
7.5.4 Lepu Naloxegol Revenue in Global Market (2018-2023)
7.5.5 Lepu Key News & Latest Developments
7.6 Daiichi Sankyo Company
7.6.1 Daiichi Sankyo Company Company Summary
7.6.2 Daiichi Sankyo Company Business Overview
7.6.3 Daiichi Sankyo Company Naloxegol Major Product Offerings
7.6.4 Daiichi Sankyo Company Naloxegol Revenue in Global Market (2018-2023)
7.6.5 Daiichi Sankyo Company Key News & Latest Developments
7.7 Knight Therapeutics
7.7.1 Knight Therapeutics Company Summary
7.7.2 Knight Therapeutics Business Overview
7.7.3 Knight Therapeutics Naloxegol Major Product Offerings
7.7.4 Knight Therapeutics Naloxegol Revenue in Global Market (2018-2023)
7.7.5 Knight Therapeutics Key News & Latest Developments
7.8 Kyowa Kirin International
7.8.1 Kyowa Kirin International Company Summary
7.8.2 Kyowa Kirin International Business Overview
7.8.3 Kyowa Kirin International Naloxegol Major Product Offerings
7.8.4 Kyowa Kirin International Naloxegol Revenue in Global Market (2018-2023)
7.8.5 Kyowa Kirin International Key News & Latest Developments
7.9 Nektar Therapeutics
7.9.1 Nektar Therapeutics Company Summary
7.9.2 Nektar Therapeutics Business Overview
7.9.3 Nektar Therapeutics Naloxegol Major Product Offerings
7.9.4 Nektar Therapeutics Naloxegol Revenue in Global Market (2018-2023)
7.9.5 Nektar Therapeutics Key News & Latest Developments
7.10 RedHill Biopharma Ltd.
7.10.1 RedHill Biopharma Ltd. Company Summary
7.10.2 RedHill Biopharma Ltd. Business Overview
7.10.3 RedHill Biopharma Ltd. Naloxegol Major Product Offerings
7.10.4 RedHill Biopharma Ltd. Naloxegol Revenue in Global Market (2018-2023)
7.10.5 RedHill Biopharma Ltd. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Naloxegol Market Opportunities & Trends in Global Market
Table 2. Naloxegol Market Drivers in Global Market
Table 3. Naloxegol Market Restraints in Global Market
Table 4. Key Players of Naloxegol in Global Market
Table 5. Top Naloxegol Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Naloxegol Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Naloxegol Revenue Share by Companies, 2018-2023
Table 8. Global Companies Naloxegol Product Type
Table 9. List of Global Tier 1 Naloxegol Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Naloxegol Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Naloxegol Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Naloxegol Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Naloxegol Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Naloxegol Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Naloxegol Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Naloxegol Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Naloxegol Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Naloxegol Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Naloxegol Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Naloxegol Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Naloxegol Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Naloxegol Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Naloxegol Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Naloxegol Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Naloxegol Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Naloxegol Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Naloxegol Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Naloxegol Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Naloxegol Revenue, (US$, Mn), 2024-2029
Table 30. MOVANTIK Company Summary
Table 31. MOVANTIK Naloxegol Product Offerings
Table 32. MOVANTIK Naloxegol Revenue (US$, Mn) & (2018-2023)
Table 33. MOVANTIK Key News & Latest Developments
Table 34. AstraZeneca Company Summary
Table 35. AstraZeneca Naloxegol Product Offerings
Table 36. AstraZeneca Naloxegol Revenue (US$, Mn) & (2018-2023)
Table 37. AstraZeneca Key News & Latest Developments
Table 38. Aurobindo Company Summary
Table 39. Aurobindo Naloxegol Product Offerings
Table 40. Aurobindo Naloxegol Revenue (US$, Mn) & (2018-2023)
Table 41. Aurobindo Key News & Latest Developments
Table 42. MSN Life Sciences Company Summary
Table 43. MSN Life Sciences Naloxegol Product Offerings
Table 44. MSN Life Sciences Naloxegol Revenue (US$, Mn) & (2018-2023)
Table 45. MSN Life Sciences Key News & Latest Developments
Table 46. Lepu Company Summary
Table 47. Lepu Naloxegol Product Offerings
Table 48. Lepu Naloxegol Revenue (US$, Mn) & (2018-2023)
Table 49. Lepu Key News & Latest Developments
Table 50. Daiichi Sankyo Company Company Summary
Table 51. Daiichi Sankyo Company Naloxegol Product Offerings
Table 52. Daiichi Sankyo Company Naloxegol Revenue (US$, Mn) & (2018-2023)
Table 53. Daiichi Sankyo Company Key News & Latest Developments
Table 54. Knight Therapeutics Company Summary
Table 55. Knight Therapeutics Naloxegol Product Offerings
Table 56. Knight Therapeutics Naloxegol Revenue (US$, Mn) & (2018-2023)
Table 57. Knight Therapeutics Key News & Latest Developments
Table 58. Kyowa Kirin International Company Summary
Table 59. Kyowa Kirin International Naloxegol Product Offerings
Table 60. Kyowa Kirin International Naloxegol Revenue (US$, Mn) & (2018-2023)
Table 61. Kyowa Kirin International Key News & Latest Developments
Table 62. Nektar Therapeutics Company Summary
Table 63. Nektar Therapeutics Naloxegol Product Offerings
Table 64. Nektar Therapeutics Naloxegol Revenue (US$, Mn) & (2018-2023)
Table 65. Nektar Therapeutics Key News & Latest Developments
Table 66. RedHill Biopharma Ltd. Company Summary
Table 67. RedHill Biopharma Ltd. Naloxegol Product Offerings
Table 68. RedHill Biopharma Ltd. Naloxegol Revenue (US$, Mn) & (2018-2023)
Table 69. RedHill Biopharma Ltd. Key News & Latest Developments
List of Figures
Figure 1. Naloxegol Segment by Type in 2022
Figure 2. Naloxegol Segment by Application in 2022
Figure 3. Global Naloxegol Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Naloxegol Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Naloxegol Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Naloxegol Revenue in 2022
Figure 8. By Type - Global Naloxegol Revenue Market Share, 2018-2029
Figure 9. By Application - Global Naloxegol Revenue Market Share, 2018-2029
Figure 10. By Type - Global Naloxegol Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Naloxegol Revenue Market Share, 2018-2029
Figure 12. By Application - Global Naloxegol Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Naloxegol Revenue Market Share, 2018-2029
Figure 14. By Region - Global Naloxegol Revenue Market Share, 2018-2029
Figure 15. By Country - North America Naloxegol Revenue Market Share, 2018-2029
Figure 16. US Naloxegol Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Naloxegol Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Naloxegol Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Naloxegol Revenue Market Share, 2018-2029
Figure 20. Germany Naloxegol Revenue, (US$, Mn), 2018-2029
Figure 21. France Naloxegol Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Naloxegol Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Naloxegol Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Naloxegol Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Naloxegol Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Naloxegol Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Naloxegol Revenue Market Share, 2018-2029
Figure 28. China Naloxegol Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Naloxegol Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Naloxegol Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Naloxegol Revenue, (US$, Mn), 2018-2029
Figure 32. India Naloxegol Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Naloxegol Revenue Market Share, 2018-2029
Figure 34. Brazil Naloxegol Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Naloxegol Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Naloxegol Revenue Market Share, 2018-2029
Figure 37. Turkey Naloxegol Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Naloxegol Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Naloxegol Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Naloxegol Revenue, (US$, Mn), 2018-2029
Figure 41. MOVANTIK Naloxegol Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. AstraZeneca Naloxegol Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Aurobindo Naloxegol Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. MSN Life Sciences Naloxegol Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Lepu Naloxegol Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Daiichi Sankyo Company Naloxegol Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Knight Therapeutics Naloxegol Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Kyowa Kirin International Naloxegol Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Nektar Therapeutics Naloxegol Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. RedHill Biopharma Ltd. Naloxegol Revenue Year Over Year Growth (US$, Mn) & (2018-2023)

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ ナロキセゴールの世界市場見通し2023年-2029年(Naloxegol Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

ナロキセゴールの世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp